Modern approaches to using the FreeStyle Libre Flash glucose monitoring system


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The world has already accumulated extensive experience in the use of continuous glycemic monitoring using the FreeStyle Libre Flash monitoring system in patients with diabetes mellitus. The article presents an analysis of recent publications on this issue. Based on the data analyzed, it can be argued that the use of the FreeStyle Libre Flash monitoring system in patients with DM1 and DM2 on insulin therapy can lead to a decrease in the level of glycated hemoglobin and glycemic variability, a significant decrease in the number and duration of hypoglycemic episodes, the risk of developing ketoacidosis, and an improvement in quality of life indicators.

Full Text

Restricted Access

About the authors

Nikolai A. Demidov

Moskovsky City Hospital of the Moscow Healthcare Department

Email: nicolay13@mail.ru
Cand. Sci. (Med.), endocrinologist build. 7, microdistr. 3, Moscovsky City, Moscow 108811, Russian Federation

O. M Koteshkova

Endocrinological Dispensary of the Moscow Healthcare Department

Moscow, Russia

M. B Antsiferov

Endocrinological Dispensary of the Moscow Healthcare Department

Moscow, Russia

References

  1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-86. doi: 10.1056/NEJM199309303291401.
  2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-53.
  3. Mazze R.S. Making sense of glucose monitoring technologies from SMBG to CGM. Diabet Technol Ther. 2005;7:784-87. Doi: 10.1089/ dia.2005.7.784.
  4. Анциферов М.Б., Галстян Г.Р, Зилов А.В. и др. Резолюция по итогам первой рабочей встречи научно-консультативного совета по вопросу «актуальные проблемы вариабельности гликемии как нового критерия гликемического контроля и безопасности терапии сахарного диабета». Сахарный диабет. 2019;22(3):281-88.
  5. Monnier L, Colette C., Wojtusciszyn A., et al. Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes. Diabet Care. 2017;40(7):832-38. Doi: 10.233 7/ dc16-1769.
  6. Danne T., Nimri R., Battelino T., et al. International Consensus on Use of Continuous Glucose Monitoring. Diabet Care. 2017;40:1631-40. doi: 10.2337/dc17-1600.
  7. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359:1464-76. Doi: 10.1056/ NEJMoa0805017.
  8. Beck R.W., Riddlesworth T., Ruedy K., et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections. The DIAMOND randomized clinical trial. JAMA. 2017;317:371-78. doi: 10.1001/jama.2016.19975.
  9. Beck R.W., Riddlesworth T., Ruedy K., et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med. 2017;167:365-74. doi: 10.7326/M16-2855.
  10. Lind M., Polonsky W., Hirsch I.B., et al. Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial. JAMA. 2017;317:379-87.
  11. Beck R.W., Riddlesworth T., Ruedy K., et al. For the DIAMOND Study Group. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections The DIAMOND Randomized Clinical Trial. JAMA. 2017; 317(4):371-78. doi: 10.1001/jama.2016. 19975.
  12. Polonsky W., Hirsch B., Heise T., et al. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections The GOLD Randomized Clinical Trial Marcus Lind, JAMA. 2017;317(4):379-87. doi: 10.1001/jama.2016.19976, Corrected on May 9, 2017.
  13. Beck R.W., Riddlesworth T.D., Ruedy K., et al. For the DIAMOND Study Group*. Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: a randomized trial. Ann Intern Med. 2017;167:365-74.
  14. Campbell F., Murphy N., Stewart C., et al. Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study. Paediatr Diabet. 2018;19(7):1294-1301. doi: 10.1111/pedi.12735.
  15. Bolinder J., Antuna R., Geelhoed-Duijvestijn P., et al. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, nonmasked, randomised controlled trial. Lancet. 2016;388:2254-63.
  16. Haak T., Hanaire H., Ajjan R., et al. Flash glucosesensing technology as a replacement for blood glucose monitoring for the management of insulintreated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabet Ther.2017;8:55-73.
  17. Bidonde J., Fagerlund B.C., Frnsdal K.B., et al. FreeStyle Libre Flash Glucose Self-Monitoring System: A Single-Technology Assessment [Internet]. Report from the Norwegian Institute of Public Health No. 2017-07. Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Aug 21.
  18. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283:2008-12. doi: 10.1001/jama.283.15.2008.
  19. von Elm E., Altman D.G., Egger M., et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12:1495-9. doi: 10.1016/j.ijsu.2014.07.013.
  20. Evans M., Welsh Z., Ells S., Seibold A. The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: A Meta-analysis of Clinical Trials and Real-World Observational Studies. Diabet Ther. 2020;11:83-95. doi: 10.1007/s13300-019-00720-0.
  21. Eeg-Olofsson K., Svensson A.-M., Franzén S., et al. Sustainable HbA1c Decrease at 12 Months for Adults with Type 1 and Type 2 Diabetes Using the FreeStyle Libre System: A Study within the National Diabetes Register in Sweden. Diabet. 2020;69(Suppl. 1):74-LB. Doi: 10.2337/ db20-74-LB.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies